BlackRock Fund Advisors’s Bio-Path Holdings Inc BPTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$3.83M Buy
709
+95
+15% +$460K ﹤0.01% 3016
2016
Q3
$3.44M Buy
614
+72
+13% +$462K ﹤0.01% 3024
2016
Q2
$4.31M Buy
542
+493
+1,006% +$4.99M ﹤0.01% 2882
2016
Q1
$508K Sell
49
-4
-8% -$25.9K ﹤0.01% 3240
2015
Q4
$264K Buy
53
+3
+6% +$17.5K ﹤0.01% 3426
2015
Q3
$230K Sell
50
-2
-4% -$9.38K ﹤0.01% 3417
2015
Q2
$238K Sell
52
-458
-90% -$2.5M ﹤0.01% 3458
2015
Q1
$3.68M Sell
510
-3
-0.6% -$25.2K ﹤0.01% 2980
2014
Q4
$5.46M Buy
513
+79
+18% +$816K ﹤0.01% 2827
2014
Q3
$3.49M Sell
434
-18
-4% -$174K ﹤0.01% 2951
2014
Q2
$5.51M Buy
+452
New +$4.95M ﹤0.01% 2779

Other funds holding BPTH

BlackRock Fund Advisors's BPTH Position: Q4 2016 in Review

BlackRock Fund Advisors increased its Bio-Path Holdings Inc (BPTH) stake by 15% in Q4 2016, buying an estimated $460K and bringing the position to 709 shares worth $3.83M. The position accounts for ﹤0.01% of the portfolio, ranked #3016.

BlackRock Fund Advisors first reported a position in BPTH in Q2 2014 and has held it in 11 quarters since. The position peaked at $5.51M in Q2 2014. 48 funds tracked by Wall St. Rank hold BPTH as of Q4 2016.

  • BlackRock Fund Advisors held 709 shares of Bio-Path Holdings Inc worth $3.83M as of Q4 2016.
  • BlackRock Fund Advisors bought 95 Bio-Path Holdings Inc shares in Q4 2016, an estimated $460K.
  • Bio-Path Holdings Inc made up ﹤0.01% of BlackRock Fund Advisors's portfolio in Q4 2016, its #3016 holding.
  • BlackRock Fund Advisors first reported a position in Bio-Path Holdings Inc in Q2 2014 and has held it in 11 quarters since.
  • BlackRock Fund Advisors's Bio-Path Holdings Inc position peaked at $5.51M in Q2 2014.
  • 48 funds tracked by Wall St. Rank held Bio-Path Holdings Inc as of Q4 2016.

Based on BlackRock Fund Advisors's 13F filing for Q4 2016, filed 10 Feb 2017.